| |
|
Sofosbuvir/Ledipasvir in Treatment of Early (Acute) HCV Infection in HIV+ Men
|
| |
| |
Reported by Jules Levin
EASL 2017
7. Conclusions
o All 22 (100%) HIV-infected men with early HCV were cured with short-course (8-week) SOF/LDV in h=this Real-World setting using broad enrollment and treatment criteria.
o For future research, better definitions of early HCV infection are needed to determine eligibility for short-course treatment.
o For clinical practice, early HCV infection should be treated as soon as possible after clinical onset to take advantage of short-course treatments, as well as to decrease transmission among HIV-infected MSM.
| |
| |
| |
|
|
|
